A thin layer of cream omnadren 250 jelfa is applied to the affected skin once daily. The duration of treatment: 7 – 28 days, determined by the effectiveness of therapy, and patient tolerability of the drug, the presence and severity of side effects.
Precautions for the use of
the absence of effect within 2 weeks of therapy should clarify the diagnosis.
When applied to large areas of the skin for a long time, especially in the application of occlusive dressings may develop corticosteroids systemic effects. Given this, it is necessary to control the function of the hypothalamic-pituitary-adrenal system.
Do not use in ophthalmology.
Avoid getting product in eyes.
Propylene glycol, which is part of omnadren 250 jelfa , may cause irritation at the site of application. In such cases, use of the drug should be discontinued and appropriate treatment.
When you join secondary infection prescribe antimicrobial therapy. Keep in mind that steroids are capable of changing manifestations of certain skin diseases, which may hinder the diagnosis. In addition, the use of corticosteroids may be the cause of the delay wound healing.
Caution should be exercised when applied to the skin of the face and intertriginous skin surface, the use of occlusive dressings, as well as the treatment of large areas of skin and / or long-term treatment (particularly in children).
Overdose symptoms, relief measures in overdose
Symptoms: inhibition of the function of the hypothalamic-pituitary-adrenal system (including secondary adrenal insufficiency). Treatment: symptomatic. If necessary – correction of electrolyte imbalance, removal of the drug (for long-term treatment – phasing out).
Features of the drug at its cancellation
after prolonged treatment with glucocorticosteroids sudden cessation of therapy can lead to rebound syndrome, which manifests itself in the form of dermatitis with intense redness and burning sensation. So after prolonged treatment abolition of the drug should be made gradually, for example, going to the intermittent regimen before its full stop.
burning, itching, paresthesia, folliculitis, acne, skin atrophy, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, the accession of secondary infection, striae, miliaria. The likelihood of these adverse effects increases with the use of occlusive dressings.
the application of external forms of corticosteroids for a long time and / or for the treatment of large areas of skin (the total area of applying the palm of the patient over area) or by using occlusive dressings, especially in children and adolescents, the side effects characteristic of glucocorticosteroids may occur systemic effects, including adrenal insufficiency and omnadren 250 jelfa syndrome.
Interaction with other medicinal products is not revealed.
Application of pregnancy and during breastfeeding
Safety during pregnancy and lactation has not been studied.
Corticosteroids cross the placental barrier. Avoid long-term treatment and the use of large doses during pregnancy due to the risk of negative effects on fetal development. Appoint during pregnancy in cases where the expected benefit to the mother outweighs the potential risk to the fetus; with the use of small dose and apply a short time.
Glucocorticosteroids are excreted in breast milk. In the case where glucocorticosteroids expected at high doses and / or for a long time, discontinue breastfeeding.
in connection with the fact that in children the value of the ratio of surface area and body weight greater than that of adults, children are at greater risk of suppression of the hypothalamic-pituitary-adrenal system and the development of the syndrome Cushing when applying any topical corticosteroids. Prolonged use of topical corticosteroids in children can lead to disruption of their growth and development.Use of the drug in children for more than 3 weeks has not been studied.
Children should receive the lowest dose omnadren 250 jelfa, sufficient to achieve the effect.